Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Revenue (2021 - 2025)

Historic Revenue for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $81.1 million.

  • Core Scientific's Revenue fell 1494.54% to $81.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.2 million, marking a year-over-year decrease of 4007.61%. This contributed to the annual value of $510.7 million for FY2024, which is 164.65% up from last year.
  • Latest data reveals that Core Scientific reported Revenue of $81.1 million as of Q3 2025, which was down 1494.54% from $78.6 million recorded in Q2 2025.
  • Core Scientific's Revenue's 5-year high stood at $301.8 million during Q4 2021, with a 5-year trough of $54.2 million in Q1 2021.
  • Over the past 5 years, Core Scientific's median Revenue value was $120.7 million (recorded in 2023), while the average stood at $128.3 million.
  • The largest annual percentage gain for Core Scientific's Revenue in the last 5 years was 25489.99% (2022), contrasted with its biggest fall of 5982.37% (2022).
  • Quarter analysis of 5 years shows Core Scientific's Revenue stood at $301.8 million in 2021, then plummeted by 59.82% to $121.2 million in 2022, then rose by 17.05% to $141.9 million in 2023, then plummeted by 33.12% to $94.9 million in 2024, then dropped by 14.56% to $81.1 million in 2025.
  • Its Revenue stands at $81.1 million for Q3 2025, versus $78.6 million for Q2 2025 and $79.5 million for Q1 2025.